Both in Biotechnology
Agenus vs SAB Biotherapeutics
Over the past year AGEN returned +72.3% and SABS returned +3.1%; their daily moves had a correlation of 0.19.
AGEN +72.3% SABS +3.1%Growth of $1, one year, split-adjusted
| Metric | AGEN | SABS |
|---|---|---|
| Price | $6.84 | $3.35 |
| Market cap | $308.9M | $304.8M |
| Today | −3.53% | +3.72% |
| 1 month | −17.9% | +9.5% |
| 6 months | +78.1% | −3.5% |
| Year to date | +117.8% | −10.4% |
| 1 year | +77.7% | +10.2% |
| Revenue growth (YoY) | +34.4% | — |
| Gross margin | 100.0% | — |
| Net margin | −1.7% | — |
| P/E (TTM) | 3.4× | — |
| Price / sales | 2.3× | — |
| Net cash | -$11.3M | $99.4M |
| Dividend yield | — | — |
| Volatility (60d) | 89.2% | 55.7% |
| Short % of float | 16.6% | 6.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).